Histone acetyltransferases (HATs) and histone deacetylases (HDACs) play a crucial role in gene expression through reversible acetylation and deacetylation of histones. HAT-mediated hyperacetylation of lysine residues in the N-terminal tails of core histones loosens the histone-DNA binding and activates gene transcription. In contrast, HDAC-catalyzed deacetylation of acetylated lysine residues leads to tight histone-DNA binding, which restricts the access of transcriptional factors.
Recently, X-ray crystallographic analysis has disclosed the interaction mode between the HDAC-like protein (HDLP) from the bacterium Aquifex aeolicus and the natural HDAC inhibitor TSA from actinomyces; TSA binds inside the pocket of HDLP, making tight contacts with residues at the rim, walls, and bottom of the pocket. The zinc ion near the bottom is coordinated by the hydroxamic acid of TSA. 9) For the design of a new series HDAC inhibitors, we chose a benzyl component for interaction with the walls of a HDAC pocket, a bicyclic arylcarbonyl component for capping the pocket, and the hydroxamic acid for capture of the zinc ion at the bottom. Among the synthesized HDAC inhibitors, compound 1 showed promising inhibitory efficacies against the proliferation of HCT116 human colorectal carcinoma cells (IC 50 0.7 mM) and HDACs activities (IC 50 0.044 mM) ( Table  1) . 10) Further improvement of the pharmacokinetic profile afforded the nitrogen-introduced compounds 2-4. These compounds were improved in water solubility. Compound 2 exhibited inhibitory activities stronger than those of suberoylanilide hydroxamic acid (SAHA) against a panel of cancer cells as well as the maximal 185% T/C of survival rate in the experiments with P388 cell-inoculated mice. 11) In the present study, we synthesized two derivatives 5 and 6 with a structural component (2,6-naphthylene or thiol group) other than those of the HDAC inhibitors 1-4 to determine whether these groups can be substitutes for phenylene and hydroxamic acid groups in 1-4, making contacts with the walls and zinc ion of the HDAC pocket, respectively. We also examined whether the inhibitory effects on cancer cell proliferation by the novel histone deacetylase inhibitors involve p21/WAF1 induction and G 1 or G 2 /M arrest as do other HDAC inhibitors through assessment of Western blot, luciferase, and cell cycle progression assays.
Chemistry Compounds 5 and 6 were synthesized in the following way (Chart 1): Condensation of methyl 6-amino-2-naphthoate hydrochloride and phenylacetyl chloride in the presence of Et 3 N gave 5a, which, after conversion to carboxylic acid 5b, was reacted with BOP-Cl and O-benzylhydroxyamine hydrochloride to give 5c. It was then hydrogenated over 10% Pd-C, yielding the desired 5. Condensation [4-(aminomethyl) phenyl]methanol and phenylacetyl chloride in the presence of Et 3 N gave 6a, which was treated with HBr to give benzyl brimide 6b. Replacement reaction of bromine (6b) with thio-ureido (6c) followed by alkaline treatment yielded the desired 6.
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MATERIAL AND METHODS
Melting points were determined on a Yanagimoto MP-32 micromelting point apparatus and are uncorrected. IR spectra were recorded on Shimadzu FTIR-8400 infrared spectrophotometer. Low-resolution (LR)-FAB-MS spectra were measured on a JEOL JMS-HX 100 instrument, whereas high-resolution (HR)-and LR-electron impact (EI)-MS spectra were measured on a JEOL The Tandem MStation JMS-700.
1 H-NMR spectra were recorded on JEOL EX-270 (270 MHz) and JEOL EX-400 (400 MHz) instruments using tetramethylsilane as an internal standard. Analytical TLC and PLC were performed using Silica gel 60 F 254 (Merck, 0.25 and 0.5 mm, respectively) glass plates. Column chromatography was performed using Silica Gel 60 (70-230 mesh ASTM). TSA was purchased from Sigma-Aldrich Co.
Methyl 6-[(Phenylacetyl)amino]-2-naphthoate (5a) To a suspension of methyl 6-amino-2-naphthoate hydrochloride (3.0 g, 14.9 mmol) in absolute DMF (60 ml) were added Et 3 N (8.3 ml, 60.0 mmol) and phenylacetyl chloride (2.16 ml, 16.4 mmol). The mixture was stirred at room temperature overnight. After being evaporated, the residue was dissolved in CHCl 3 (200 ml) and washed successively with 1 N HCl (3ϫ50 ml), saturated NaHCO 3 (3ϫ50 ml), and brine (3ϫ 50 ml). The organic layer was dried and concentrated to dryness. The resulting residue was recrystallized from CHCl 3 -nhexane to give the pure compound 5a ( 6-[(Phenylacetyl)amino]-2-naphthoic Acid (5b) LiOH 1 M (7.8 ml, 7.8 mmol) was added to a solution of 5a (1.1 g, 3.5 mmol) in a mixture of water (0.5 ml) and THF (15.1 ml), and the mixture was stirred at room temperature overnight. After evaporation of THF, the residual water solution was adjusted to pH 3 with 1 N HCl. The resulting precipitate was filtered off and washed with water to give the pure compound 5b (1.0 g, 3.3 mmol, 94% yield). mp 361. N-(Benzyloxy)-6-[(phenylacetyl)amino]-2-naphthamide (5c) To a suspension of O-benzylhydroxylamine hydrochloride (0.31 g, 1.97 mmol) in absolute DMF (8.2 ml) were added 5b (0.50 g, 1.6 mmol), BOP-Cl (0.50 g, 1.96 mmol), and Et 3 N (0.67 ml, 4.8 mmol). The mixture was stirred at room temperature overnight. After being evaporated, the residue was dissolved in CHCl 3 (100 ml) and washed successively with 1 N HCl (3ϫ20 ml), saturated NaHCO 3 (3ϫ20 ml), and brine (3ϫ20 ml). The organic layer was dried over Na 2 SO 4 and concentrated. The resulting residue was recrystallized from EtOAc to give the pure compound 5c (0.15 g, 0.37 mmol, 23% yield). mp 229. 6 12) IC 50 values in Table 1 represent the molar concentrations (mM) required to inhibit the HDACs by 50%.
Cell Culture HCT116 cells (purchased from the ATCC) were cultured in McCoy's 5a medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS), streptomycin 2.5 mg/ml, and penicillin 2.5 units/ml at 37°C in a humidified atmosphere of 5% CO 2 . Cells were passaged every 2 d into 60-mm dishes by washing twice with phosphatebuffered saline (PBS) and incubated with 0.25% trypsin and 0.03% EDTA for 5 min at 37°C prior to resuspension in growth medium. MG63 human osteosarcoma cells (kindly provided by Dr. Y. Yanase, Wakayama Medical College) were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% FBS, streptomycin 10 mg/ml, and penicillin 10 units/ml at 37°C in a humidified atmosphere of 5% CO 2 . Cells were passaged every 3 d into 100-mm dishes by washing twice with PBS and incubated with 0.05% trypsin and 0.02% EDTA for 3 min at 37°C prior to resuspension in growth medium.
Evaluation of Growth Inhibition against HCT116 Cells Cells were plated in 96-well plates at densities of 1.0ϫ10 5 /ml. On the same day, compounds were added, and the cells were cultured for 2 d. After addition of WST-1 and 1-methoxy-5-methyl-phenazinium methylsulfate, the OD 450 and OD 630 were measured in the conventional way.
11)
Analysis of Cell Cycle Progression Cells were removed from culture dishes by trypsinization and collected by centrifugation. After washing with PBS, cells were suspended in PBS containing 0.1% Triton X-100 to prepare nuclei. After the suspension was filtered through 50-nm nylon mesh, 0.1% RNase and 50 mg/ml propidium iodide were added. DNA contents in stained nuclei were analyzed with FACSCalibur (Becton Dickinson). The suspension of cells was analyzed for each DNA histogram. The number of stained nuclei in each phase was measured according to the Mod FitLT program in the FACSCalibur system.
Plasmid Transfection an Assessment of Luciferase Assay The human wild-type p21/WAF1 promoter, pWWPLuc, was a kind gift from Dr. B. Vogelstein. Transient transfection was performed at 60% confluency in 12-well titer plates with the calcium phosphate technique using Cellphect transfecting agent (Amersham-Pharmacia). Luciferase activities were measured using a luminometer, and were normalized for the amount of the protein in cell lysates. All experiments were carried out in triplicate.
Western Blot Analysis MG63 cells in 100-mm plates were treated with 1-6 at the various concentrations indicated in DMEM for 24 h. After the medium was aspirated, the cells were washed with cold PBS and ice-cold radioimmunoprecipitation assay (RIPA) buffer. Western blot analysis was performed using mouse monoclonal antibody recognizing p21 (PM15091A from Pharmingen) as the primary antibody. The signal was detected with a chemiluminescence system (ECL, Amersham-Pharmacia). Protein concentration was determined using the Bio-Rad Protein Assay Kit.
RESULTS AND DISCUSSION Table 1 shows the inhibitory activities of 1-6 against the proliferation of HCT116 cells as well as HDACs. Compounds 1-4 had comparatively low IC 50 values (HCT116, 0.7-3.9 mM; HDAC, 0.026-0.044 mM). However, replace- 1, 2, 3, 4 , 5, or 6 as indicated or 0.1% DMSO for 24 h were examined using SDS-polyacrylamide gel electrophoresis and analyzed with immunoblotting using antibodies for p21/WAF1 and a-tubulin. ment of the 1,4-phenylene and 2-naphthylcarbonyl group in 1 with the 2,6-naphthylene and phenylcarbonyl group in 5 as well as of hydroxamic acid in 1 with thiol in 6 resulted in much greater IC 50 values.
We analyzed the effects of 1-6 and TSA on p21/WAF1 protein expression in MG63 cells. As shown in Fig. 1 , treatment with 1-6 induced p21/WAF1 protein expression in a dose-dependent manner in Western blot analysis, although the protein levels induced by 5 and 6 were much lower than those by 1-4, in consonance with the low HDAC and HCT116 inhibition of 5 and 6. In contrast, the level of alphatubulin was unaltered by each treatment (Fig. 1) . We thus investigated whether these compounds could stimulate the activity of the p21/WAF1 gene promoter in cells transiently transfected with the 2.4-kb wild-type p21/WAF1 promoterluciferase fusion plasmid pWWP-Luc. The p21/WAF1 gene promoter activity was markedly stimulated by 1-4, in line with the enhancement of the protein expression, as illustrated in Fig. 2 . Further, the effects of these compounds on cell cycle progression of MG63 cells were investigated by measuring the DNA content of nuclei of MG63 cells with flow cytometry. Exposure to 1 mM of 4 or to 10 mM each of 1, 2, and 3 for 24 h apparently decreased S-phase cells, whereas it caused accumulation of cells in the G 2 /M phase (Fig. 3) . Interestingly, the levels of p21/WAF1 gene expression and G 2 /M phase accumulation were mutually correlated. We have so far shown that p21/WAF1 is upregulated by HDAC inhibitors including TSA and sodium butyrate in MG63 cells; this was associated with G 2 /M arrest 7) It is also known that enhancement of p21/WAF1 causes G 1 arrest. 13) p21/WAF1 inhibits cyclin-dependent kinase (CDK) activities such as CDK2, CDK4, or CDK6 promoting G 1 /S-phase transition. 13) In addition to its role in G1 transition, p21/WAF1 reaccumulates in nuclei near the G 2 /M boundary and causes a transient block in the late G 2 phase. 14) In addition to CDK regulation, p21/WAF1 binds directly to PCNA, which is associated with DNA replication and cell proliferation. 15) The observed increase in the p21/WAF1 level as well as the cell cycle arrest in the G 2 /M phase strongly suggest that 1-4 are potent inhibitors of cell cycle progression. Although the p21/WAF1 gene is a p53-regulated one, 16) it was upregulated by 1, 2, 3, or 4 in the p53-mutated MG63 cells. Since the p53 gene is frequently mutated, 17) clarification of the p53-independent activating pathway of the p21/WAF1 gene might contribute to cancer therapy. 852 Vol. 28, No. 5 
